Contact
searchSearch
HMP Global
Clinical Videos

Video Supplement: When the Left Ventricle Dances: Ballerina Foot Appearance in Hypertrophic Cardiomyopathy

Mohit Gupta, MD
Anwar Hussan Ansari, MD, DM
Puneet Gupta, MD, DM
Anunay Gupta, MD, DM
Devesh Kumar, MD, MRCP, DM
05/27/2026

Video 1. Coronary angiogram in the right anterior oblique cranial view with evidence of dynamic compression (milking) seen in the distal left anterior descending artery as a sign of myocardial bridging.

Video 2. Left ventricular (LV) angiogram in the right anterior oblique view with evidence of significant hypercontractility in the basal and mid-segments of the LV and subsequent narrowing of the mid-LV during systole, giving it a “ballerina foot” deformity.

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


Related Content

Clinical Images
When the Left Ventricle Dances: Ballerina Foot Appearance in Hypertrophic Cardiomyopathy
05/27/2026
Mohit Gupta, MD; Anwar Hussan Ansari, MD, DM; Puneet Gupta, MD, DM; Anunay Gupta, MD, DM; Devesh Kumar, MD, MRCP, DM
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with...
05/27/2026
Journal of Invasive Cardiology
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest
Hypertrophic cardiomyopathy
Real-World Outcomes of Camzyos (mavacamten) Across Four Continents Presented at the European Society of Cardiology (ESC) Congress 2025
09/04/2025
The data further supports the growing body of evidence for Camzyos, a cardiac myosin inhibitor, as a standard of care for NYHA class II-III symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
The data further supports the growing body of evidence for Camzyos, a cardiac myosin inhibitor, as a standard of care for NYHA class II-III symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
The data further supports the...
09/04/2025
Cath Lab Digest
Hypertrophic Cardiomyopathy (HCM)
American College of Cardiology Launches HCM Digital Registry
08/21/2025
08/21/2025
Cath Lab Digest

News

Vertex Catheter (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026
05/26/2026
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the...
05/26/2026
Cath Lab Digest
Uncontrolled Hypertension
AstraZeneca's Baxfendy Approved in U.S. as Aldosterone Synthase Inhibitor Treatment for Adults With Hypertension
05/26/2026
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
...
05/26/2026
Cath Lab Digest
Gene-Editing Approaches
Single Dose of Lilly's PCSK9 Base Editor, VERVE-102, Reduced PCSK9 by up to 88% and LDL-C by up to 62%, With Durable Effects Supporting Potential as One-Time Hypercholesterolemia Treatment
05/26/2026
Eli Lilly and Company announced positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine designed to durably turn off the PCSK9 gene in the liver and lower blood low-density lipoprotein...
Eli Lilly and Company announced positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine designed to durably turn off the PCSK9 gene in the liver and lower blood low-density lipoprotein...
Eli Lilly and Company announced...
05/26/2026
Cath Lab Digest
Inflammation
Cardiometabolic Clinical Data Support Potential of NodThera's Ruvonoflast to Treat Inflammation at the Source
05/26/2026
Boston, MA –  NodThera, a clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, announced the...
Boston, MA –  NodThera, a clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, announced the...
Boston, MA –  NodThera, a...
05/26/2026
Cath Lab Digest
Intravascular Lithotripsy
AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study
05/21/2026
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular...
05/21/2026
Cath Lab Digest
Stent Clinical Trials
Reflow Medical Reports Six-Month Results from DEEPER CORONARY Study of Spur® Elute Stent
05/20/2026
DEEPER CORONARY is a first-in-human pilot study designed to evaluate the short-term safety of the investigational coronary Spur Elute System as a primary treatment for coronary ISR.
DEEPER CORONARY is a first-in-human pilot study designed to evaluate the short-term safety of the investigational coronary Spur Elute System as a primary treatment for coronary ISR.
DEEPER CORONARY is a...
05/20/2026
Cath Lab Digest
Head-to-Head Trials
SMART Trial Three-Year Data Demonstrate Superior Benefits With Evolut TAVR™ System
05/20/2026
EuroPCR Hot Line Science features positive outcomes from the largest international head-to-head comparative trial of TAVR.
EuroPCR Hot Line Science features positive outcomes from the largest international head-to-head comparative trial of TAVR.
EuroPCR Hot Line Science...
05/20/2026
Cath Lab Digest
Thrombectomy
Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio
05/20/2026
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS...
05/20/2026
Vascular Disease Management
IVL Clinical Trial
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
05/19/2026
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
EMPOWER CAD, a global...
05/19/2026
Cath Lab Digest
Intravascular Lithotripsy
Cagent Vascular Reports First Human Use of Serranator® SONIC IVL System and Closes Oversubscribed $41M Series D Financing
05/19/2026
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical...
05/19/2026
Vascular Disease Management

Latest

Clinical Images
When the Left Ventricle Dances: Ballerina Foot Appearance in Hypertrophic Cardiomyopathy
05/27/2026
Mohit Gupta, MD; Anwar Hussan Ansari, MD, DM; Puneet Gupta, MD, DM; Anunay Gupta, MD, DM; Devesh Kumar, MD, MRCP, DM
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with...
05/27/2026
Journal of Invasive Cardiology
Original Contribution
Impact of Ultra-High-Pressure OPN NC Balloons in Complex Coronary Interventions: Indications, Safety, and Efficacy
05/27/2026
Miguel Ángel Montilla-Garrido, MD; Santiago Jesús Camacho-Freire, MD, PhD, Prof; Elena Izaga-Torralba, MD, PhD; Carmen Lluch-Requerey, MD; Jessica Roa-Garrido, MD; Oscar Lagos-De Grande, MD; Antonio Enrique Gómez-Menchero, MD
The study evaluated the indication for the use, safety, and efficacy of the OPN NC balloon (SIS Medical AG) in real-world settings.
The study evaluated the indication for the use, safety, and efficacy of the OPN NC balloon (SIS Medical AG) in real-world settings.
The study evaluated the...
05/27/2026
Journal of Invasive Cardiology
Clinical Images
Endovascular Repair of Recurrent Coarctation With Pseudoaneurysm After Prior Bare-Metal Stent Using Thoracic Branched Endoprosthesis
05/22/2026
Pradyumna Agasthi, MD; Kaitlyn Krebushevski, MD; Allison K. Cabalka, MD; Jason H. Anderson, MD
The authors report use of a thoracic branch endoprostheses to treat recurrent coarctation of the aorta in a patient presenting with an aortic pseudoaneurysm and a peak-to-peak gradient of 29 mm Hg between the ascending and descending aorta.
The authors report use of a thoracic branch endoprostheses to treat recurrent coarctation of the aorta in a patient presenting with an aortic pseudoaneurysm and a peak-to-peak gradient of 29 mm Hg between the ascending and descending aorta.
The authors report use of a...
05/22/2026
Journal of Invasive Cardiology
Clinical Images
Endovascular Management for Symptomatic Superior Vena Cava Syndrome in a Patient on Hemodialysis
05/21/2026
Keshav Sachdeva, MD, DM; Hardik Jain, MD, DM; Suraj Kumar, MD, DM; Tejinder Singh Malhi, MD, DM; Saurabh Nayak, MD, DM; Bhupinder Singh, MD, DM
A 59-year-old woman with end-stage renal disease undergoing maintenance hemodialysis through sequential right and left internal jugular venous catheters presented with progressive facial and neck swelling, dyspnea, and a non-functioning,...
A 59-year-old woman with end-stage renal disease undergoing maintenance hemodialysis through sequential right and left internal jugular venous catheters presented with progressive facial and neck swelling, dyspnea, and a non-functioning,...
A 59-year-old woman with...
05/21/2026
Journal of Invasive Cardiology
Original Contribution
Differential Effect of Chronic Kidney Disease on Right-Sided Extravalvular Damage in Low-Flow, Low-Gradient Aortic Stenosis
05/14/2026
Eric J. Kim, MD, MBE; Yash Prakash, MD; Hassan Beesley, MD; Grigory Manyak, MD; Mihir Prakash; Lakshay Chopra, MD; Akarsh Sharma, MD; Carlo Mannina, MD; George D. Dangas, MD, PhD; Lucy M. Safi, DO; Sahil Khera, MD, MPH; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Gilbert H.L. Tang, MD, MSc, MBA; Stamatios Lerakis, MD, PhD
The study examined the association between chronic kidney disease (CKD) and right-sided extravalvular damage within low-flow, low-gradient aortic stenosis and across each stage of CKD.
The study examined the association between chronic kidney disease (CKD) and right-sided extravalvular damage within low-flow, low-gradient aortic stenosis and across each stage of CKD.
The study examined the...
05/14/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Left Atrial Appendage Occlusion Outside the Box: New Frontiers in Patient Selection
05/08/2026
Laura Simson, MA
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr...
05/08/2026
Journal of Invasive Cardiology
Wearable AF Screening
Smartwatch Screening Detects More Atrial Fibrillation in High-Risk US Adults
05/08/2026
Laura Simson, MA
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial...
05/08/2026
Journal of Invasive Cardiology
Original Contribution
Real-World Analysis of Outcomes of Patients Undergoing Coronary Intravascular Lithotripsy Versus Atherectomy for Calcified Coronary Artery Disease: Findings From the TriNetX Database
05/04/2026
Vikash Jaiswal, MD; Muhammad Hanif, MD; Yusra Mashkoor, MBBS; Aymen Ahmed, MBBS; Gregory Mishkel, MD; Jonathan Rosenberg, MD; Mark J. Ricciardi, MD; Arman Qamar, MD, MPH
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared...
05/04/2026
Journal of Invasive Cardiology
Clinical Images
Late Endovascular Aneurysm Repair Limb Occlusion Presenting as Claudication: Lifelong Surveillance Essential
05/04/2026
Ping Hu, MD; Xin-yu Wang, MD; Ming Qi, MD; Jie Wang, MD; Xiao-Jing Ma, PhD
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with...
05/04/2026
Journal of Invasive Cardiology
Brief Communication
Clinical Outcomes After Transcatheter Aortic Valve Replacement by Sex and Subtype of Low-Flow Aortic Stenosis
05/04/2026
Eileen Galvani, MD; Oludamilola Akinmolayemi, MD, MPH; Srivatsan Swaminathan, BS; Carlo Mannina, MD; Sahil Khera, MD, MPH; Lucy M. Safi, DO; Gilbert H.L. Tang, MD, MSc, MBA; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Stamatios Lerakis, MD, PhD
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that...
05/04/2026
Journal of Invasive Cardiology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use